Auxly Capex To Revenue vs Interest Coverage Analysis

XLY Stock

CAD 0.04 0 5.26%

Auxly Cannabis financial indicator trend analysis is way more than just evaluating Auxly Cannabis Group prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Auxly Cannabis Group is a good investment. Please check the relationship between Auxly Cannabis Capex To Revenue and its Interest Coverage accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Auxly Cannabis Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Capex To Revenue vs Interest Coverage

Capex To Revenue vs Interest Coverage Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Auxly Cannabis Group Capex To Revenue account and Interest Coverage. At this time, the significance of the direction appears to have no relationship.

The correlation between Auxly Cannabis' Capex To Revenue and Interest Coverage is 0.08. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Interest Coverage in the same time period over historical financial statements of Auxly Cannabis Group, assuming nothing else is changed. The correlation between historical values of Auxly Cannabis' Capex To Revenue and Interest Coverage is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Auxly Cannabis Group are associated (or correlated) with its Interest Coverage. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Coverage has no effect on the direction of Capex To Revenue i.e., Auxly Cannabis' Capex To Revenue and Interest Coverage go up and down completely randomly.

Correlation Coefficient

0.08

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Interest Coverage

Most indicators from Auxly Cannabis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Auxly Cannabis Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Auxly Cannabis Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of the 30th of November 2024, Discontinued Operations is likely to grow to about 14.7 M, while Selling General Administrative is likely to drop about 19.5 M.

	2021	2022	2023	2024 (projected)
Total Revenue	83.8M	94.5M	101.1M	106.1M
Interest Expense	17.7M	21.6M	25.7M	26.9M

Total Revenue Interest Expense

Auxly Cannabis fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Current Assets	Other Stockholder Equity	Non Currrent Assets Other	Short Term Investments	Property Plant And Equipment Net	Inventory	Cash And Equivalents	Other Liab
Total Assets		0.85	0.57	0.64	0.9	0.44	-0.7	0.81	0.56	0.97	0.56	0.94	0.83	0.95	0.89	0.86	0.4	0.93	0.64	0.54	-0.06	-0.63	0.75	0.77	0.56	0.94
Short Long Term Debt Total	0.85		0.37	0.82	0.58	0.76	-0.88	0.89	0.19	0.89	0.19	0.89	0.9	0.95	0.96	0.62	0.68	0.92	0.67	0.38	-0.25	-0.76	0.97	0.94	0.19	0.89
Other Current Liab	0.57	0.37		0.17	0.61	0.12	-0.25	0.35	0.33	0.56	0.33	0.38	0.32	0.54	0.42	0.51	-0.09	0.45	0.67	0.43	-0.09	-0.32	0.23	0.43	0.33	0.53
Total Current Liabilities	0.64	0.82	0.17		0.26	0.79	-0.98	0.96	0.06	0.69	0.06	0.7	0.96	0.7	0.9	0.36	0.95	0.88	0.35	0.41	-0.21	-0.75	0.83	0.76	0.05	0.8
Total Stockholder Equity	0.9	0.58	0.61	0.26		0.05	-0.32	0.49	0.73	0.82	0.73	0.78	0.51	0.78	0.61	0.91	-0.01	0.68	0.53	0.47	0.06	-0.34	0.44	0.49	0.74	0.74
Net Debt	0.44	0.76	0.12	0.79	0.05		-0.85	0.75	-0.44	0.61	-0.44	0.52	0.76	0.64	0.76	0.0	0.78	0.67	0.54	0.37	-0.28	-0.82	0.87	0.87	-0.45	0.61
Retained Earnings	-0.7	-0.88	-0.25	-0.98	-0.32	-0.85		-0.97	-0.02	-0.77	-0.02	-0.74	-0.97	-0.78	-0.94	-0.37	-0.91	-0.91	-0.46	-0.46	0.25	0.8	-0.89	-0.85	0.0	-0.85
Accounts Payable	0.81	0.89	0.35	0.96	0.49	0.75	-0.97		0.22	0.84	0.22	0.84	1.0	0.84	0.97	0.54	0.84	0.97	0.51	0.56	-0.2	-0.77	0.86	0.83	0.2	0.92
Cash	0.56	0.19	0.33	0.06	0.73	-0.44	-0.02	0.22		0.34	1.0	0.49	0.21	0.34	0.24	0.87	-0.11	0.34	0.05	0.09	0.17	0.13	-0.01	-0.05	1.0	0.37
Non Current Assets Total	0.97	0.89	0.56	0.69	0.82	0.61	-0.77	0.84	0.34		0.34	0.91	0.87	0.97	0.93	0.72	0.47	0.94	0.68	0.61	-0.1	-0.75	0.83	0.87	0.34	0.96
Cash And Short Term Investments	0.56	0.19	0.33	0.06	0.73	-0.44	-0.02	0.22	1.0	0.34		0.49	0.21	0.34	0.24	0.87	-0.11	0.34	0.05	0.09	0.17	0.13	-0.01	-0.05	1.0	0.37
Net Receivables	0.94	0.89	0.38	0.7	0.78	0.52	-0.74	0.84	0.49	0.91	0.49		0.85	0.94	0.91	0.81	0.52	0.91	0.66	0.53	-0.06	-0.66	0.83	0.79	0.48	0.88
Common Stock Shares Outstanding	0.83	0.9	0.32	0.96	0.51	0.76	-0.97	1.0	0.21	0.87	0.21	0.85		0.86	0.98	0.55	0.84	0.98	0.5	0.54	-0.2	-0.78	0.88	0.85	0.2	0.93
Non Current Liabilities Total	0.95	0.95	0.54	0.7	0.78	0.64	-0.78	0.84	0.34	0.97	0.34	0.94	0.86		0.94	0.74	0.5	0.93	0.75	0.48	-0.15	-0.74	0.89	0.91	0.34	0.92
Total Liab	0.89	0.96	0.42	0.9	0.61	0.76	-0.94	0.97	0.24	0.93	0.24	0.91	0.98	0.94		0.63	0.75	0.98	0.63	0.5	-0.18	-0.8	0.93	0.92	0.24	0.94
Total Current Assets	0.86	0.62	0.51	0.36	0.91	0.0	-0.37	0.54	0.87	0.72	0.87	0.81	0.55	0.74	0.63		0.13	0.68	0.44	0.28	0.02	-0.25	0.44	0.43	0.87	0.7
Short Term Debt	0.4	0.68	-0.09	0.95	-0.01	0.78	-0.91	0.84	-0.11	0.47	-0.11	0.52	0.84	0.5	0.75	0.13		0.71	0.15	0.22	-0.2	-0.66	0.73	0.63	-0.12	0.6
Common Stock	0.93	0.92	0.45	0.88	0.68	0.67	-0.91	0.97	0.34	0.94	0.34	0.91	0.98	0.93	0.98	0.68	0.71		0.57	0.56	-0.16	-0.76	0.87	0.86	0.33	0.98
Other Current Assets	0.64	0.67	0.67	0.35	0.53	0.54	-0.46	0.51	0.05	0.68	0.05	0.66	0.5	0.75	0.63	0.44	0.15	0.57		0.52	-0.28	-0.51	0.67	0.76	0.05	0.56
Other Stockholder Equity	0.54	0.38	0.43	0.41	0.47	0.37	-0.46	0.56	0.09	0.61	0.09	0.53	0.54	0.48	0.5	0.28	0.22	0.56	0.52		0.01	-0.49	0.4	0.42	0.08	0.59
Non Currrent Assets Other	-0.06	-0.25	-0.09	-0.21	0.06	-0.28	0.25	-0.2	0.17	-0.1	0.17	-0.06	-0.2	-0.15	-0.18	0.02	-0.2	-0.16	-0.28	0.01		-0.22	-0.29	-0.32	0.17	-0.1
Short Term Investments	-0.63	-0.76	-0.32	-0.75	-0.34	-0.82	0.8	-0.77	0.13	-0.75	0.13	-0.66	-0.78	-0.74	-0.8	-0.25	-0.66	-0.76	-0.51	-0.49	-0.22		-0.78	-0.79	0.14	-0.75
Property Plant And Equipment Net	0.75	0.97	0.23	0.83	0.44	0.87	-0.89	0.86	-0.01	0.83	-0.01	0.83	0.88	0.89	0.93	0.44	0.73	0.87	0.67	0.4	-0.29	-0.78		0.96	-0.02	0.81
Inventory	0.77	0.94	0.43	0.76	0.49	0.87	-0.85	0.83	-0.05	0.87	-0.05	0.79	0.85	0.91	0.92	0.43	0.63	0.86	0.76	0.42	-0.32	-0.79	0.96		-0.05	0.82
Cash And Equivalents	0.56	0.19	0.33	0.05	0.74	-0.45	0.0	0.2	1.0	0.34	1.0	0.48	0.2	0.34	0.24	0.87	-0.12	0.33	0.05	0.08	0.17	0.14	-0.02	-0.05		0.36
Other Liab	0.94	0.89	0.53	0.8	0.74	0.61	-0.85	0.92	0.37	0.96	0.37	0.88	0.93	0.92	0.94	0.7	0.6	0.98	0.56	0.59	-0.1	-0.75	0.81	0.82	0.36

Click cells to compare fundamentals

Auxly Cannabis Account Relationship Matchups

Auxly Cannabis fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	411.6M	379.0M	450.4M	331.8M	261.9M	275.0M
Short Long Term Debt Total	99.7M	124.7M	190.1M	193.6M	159.0M	96.5M
Other Current Liab	1.4M	7.4M	1.3M	712K	492.0K	579.8K
Total Current Liabilities	29.9M	45.0M	53.7M	92.7M	107.0M	112.3M
Total Stockholder Equity	264.3M	195.9M	212.5M	90.4M	51.0M	44.7M
Net Debt	55.6M	103.5M	175.4M	179.0M	142.9M	150.0M
Retained Earnings	(189.3M)	(274.7M)	(308.5M)	(438.8M)	(483.3M)	(459.1M)
Accounts Payable	20.2M	27.2M	30.6M	33.0M	41.3M	43.4M
Cash	44.1M	21.2M	14.8M	14.6M	16.2M	15.4M
Non Current Assets Total	320.0M	287.1M	330.4M	241.9M	195.9M	205.7M
Cash And Short Term Investments	44.4M	21.5M	14.9M	14.8M	16.3M	15.6M
Net Receivables	15.6M	13.5M	31.2M	17.5M	16.7M	17.6M
Common Stock Shares Outstanding	596.4M	631.5M	783.4M	889.9M	991.0M	1.0B
Liabilities And Stockholders Equity	411.6M	379.0M	450.4M	331.8M	261.9M	275.0M
Non Current Liabilities Total	119.8M	142.4M	188.7M	153.4M	103.9M	80.0M
Total Liab	149.7M	187.4M	242.3M	246.1M	210.9M	221.4M
Total Current Assets	91.6M	91.9M	120.0M	89.9M	66.0M	33.6M
Short Term Debt	3.9M	4.7M	21.5M	58.9M	65.2M	68.4M
Common Stock	384.4M	394.6M	436.5M	444.8M	446.6M	468.9M
Other Current Assets	230K	12.7M	14.9M	3.1M	1.5M	2.0M
Other Stockholder Equity	38.9M	41.6M	44.9M	(30.5M)	39.5M	41.5M
Non Currrent Assets Other	15.6M	1.8M	1.6M	87K	6.0M	5.7M
Short Term Investments	306K	286K	140K	143K	128.7K	122.3K
Property Plant And Equipment Net	85.2M	95.4M	226.5M	195.3M	159.0M	109.1M
Inventory	27.1M	44.2M	58.9M	54.5M	31.4M	30.3M
Accumulated Other Comprehensive Income	69.1M	76.1M	84.5M	84.4M	48.3M	52.4M
Long Term Debt	90.9M	110.5M	151.4M	119.8M	81.4M	91.7M
Long Term Debt Total	95.8M	119.9M	168.6M	134.7M	154.9M	99.3M
Cash And Equivalents	44.1M	21.2M	14.8M	14.6M	13.2M	12.5M
Intangible Assets	77.4M	74.3M	74.2M	45.5M	29.9M	57.7M
Property Plant Equipment	85.2M	95.4M	226.5M	195.3M	224.6M	235.8M
Other Liab	19.0M	23.6M	22.5M	20.0M	23.1M	19.7M
Net Tangible Assets	195.8M	158.2M	93.1M	114.0M	131.1M	129.9M
Net Invested Capital	357.8M	309.7M	381.3M	264.9M	193.8M	314.5M
Long Term Investments	112.7M	87.1M	3.9M	1.1M	1.1M	1.0M
Net Working Capital	61.7M	46.9M	66.3M	(2.8M)	(39.0M)	(37.0M)
Current Deferred Revenue	4.3M	5.7M	295K	1.0	0.9	0.86
Capital Stock	384.4M	394.6M	436.5M	444.8M	446.6M	450.5M

Pair Trading with Auxly Cannabis

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Auxly Cannabis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Auxly Cannabis will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Auxly Cannabis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Auxly Cannabis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Auxly Cannabis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Auxly Cannabis Group to buy it.

The correlation of Auxly Cannabis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Auxly Cannabis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Auxly Cannabis Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Auxly Cannabis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Other Information on Investing in Auxly Stock

Balance Sheet is a snapshot of the financial position of Auxly Cannabis Group at a specified time, usually calculated after every quarter, six months, or one year. Auxly Cannabis Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Auxly Cannabis and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Auxly currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Auxly Capex To Revenue vs Interest Coverage Analysis

Capex To Revenue vs Interest Coverage

Capex To Revenue vs Interest Coverage Correlation Analysis

Correlation Coefficient

Capex To Revenue

Interest Coverage

Auxly Cannabis fundamental ratios Correlations

Auxly Cannabis Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Auxly Cannabis fundamental ratios Accounts

Pair Trading with Auxly Cannabis

Other Information on Investing in Auxly Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Shares Outstanding	+ 1.0	Accounts Payable
Cash And Short Term Investments	+ 1.0	Cash
Cash And Equivalents	+ 1.0	Cash
Cash And Equivalents	+ 1.0	Cash And Short Term Investments
Total Liab	+ 0.98	Common Stock Shares Outstanding
Common Stock	+ 0.98	Common Stock Shares Outstanding

Retained Earnings	- 0.98	Total Current Liabilities
Common Stock Shares Outstanding	- 0.97	Retained Earnings
Accounts Payable	- 0.97	Retained Earnings
Total Liab	- 0.94	Retained Earnings
Common Stock	- 0.91	Retained Earnings
Short Term Debt	- 0.91	Retained Earnings